Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025.
3 reports, 2 independent
Updated Sep 2
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Lineage Cell Therapeutics made a company announcement from Carlsbad, with Robert W. Baird & Co. hosting a presentation on September 2, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- William Demant Invest provided investment for Lineage Cell Therapeutics' preclinical development on August 26, 2025.Sub-event
Lineage Cell Therapeutics announced from Carlsbad; Robert W. Baird & Co. hosted the presentation.1 source
Keep exploring
The entities involved
-
Carlsbad
coastal city in the North County region of San Diego County, California, United States
-
Lineage Cell Therapeutics
biotechnology company
Nothing else this week.
-
Robert W. Baird & Co.
American investment firm
Coverage
Newest first; wire copies grouped- Business WireLineage Cell Therapeutics to Present at September 2025 Investor Conferences H.C. Wainwright 27th Annual Global Investment Conference Presentation on September 8, 2025 Baird's 2025 Global Healthcare C
- ZacksLineage Cell (LCTX) Reports Q2 Loss, Beats Revenue Estimates Lineage Cell (LCTX) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compare
- Business WireLineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025 CARLSBAD, Calif., August 05, 2025--(BUSINESS WIRE)--Lineage Cell Therapeutics,